Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing

July 2007

Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing.

The FDA already ordered all other SINGLE-ingredient long-acting guaifenesin products off the market in 2003 when Mucinex came out.

Now they are also targeting unapproved COMBO products that contain long-acting guaifenesin (Guaifenex, Crantex, etc). Some of these are Entex LA substitutes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote